119 related articles for article (PubMed ID: 6599704)
1. A different role of digoxin-like factor in the maintenance of elevated blood pressure in rats treated with DOCA and saline in youth or only in adulthood.
Zicha J; Stolba P; Pohlová I; Kunes J; Jelínek J
J Hypertens Suppl; 1984 Dec; 2(3):S481-3. PubMed ID: 6599704
[TBL] [Abstract][Full Text] [Related]
2. Endogenous digoxin-like factor contributes to the elevation of systemic resistance in rats exposed to high salt intake from prepuberty.
Zicha J; Kunes J; Stolba P
J Hypertens Suppl; 1985 Dec; 3(3):S17-9. PubMed ID: 2856698
[TBL] [Abstract][Full Text] [Related]
3. The importance of endogenous digoxin-like factors in rats with various forms of experimental hypertension.
Kunes J; Stolba P; Pohlová I; Jelínek J; Zicha J
Clin Exp Hypertens A; 1985; 7(5-6):707-20. PubMed ID: 4017264
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamics and the participation of pressor systems in young and adult rats with age-dependent DOCA-salt hypertension.
Zicha J; Kunes J; Lébl M; Pohlová I; Jelínek J
Physiol Bohemoslov; 1987; 36(1):89-92. PubMed ID: 2954174
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive role of endogenous digoxin-like factor in rats with experimental hypertension.
Pohlová I; Kunes J; Stolba P; Jelínek J; Zicha J
Cor Vasa; 1986; 28(4):298-305. PubMed ID: 3021389
[TBL] [Abstract][Full Text] [Related]
6. Digoxin amplifies the effects of deoxycorticosterone acetate (DOCA) in intact water-drinking rats: implications for the mechanism of DOCA hypertension?
Li M; Martin A; Liu DT; Whitworth JA
J Hypertens; 1994 May; 12(5):569-76. PubMed ID: 7930557
[TBL] [Abstract][Full Text] [Related]
7. Volume sensitive hypertension and the digoxin-like factor. Reversal by a Fab directed against digoxin in DOCA-salt hypertensive rats.
Krep H; Price DA; Soszynski P; Tao QF; Graves SW; Hollenberg NK
Am J Hypertens; 1995 Sep; 8(9):921-7. PubMed ID: 8541008
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of digoxin-like factor (DLF) and ADH during DOCA-salt and Goldblatt 2 kidney-1 clip hypertension development.
Vargas F; Casanova I; Haro JM; Luna JD; Garcia del Rio C
Horm Metab Res; 1990 Jun; 22(6):352-5. PubMed ID: 2199365
[TBL] [Abstract][Full Text] [Related]
9. The antihypertensive effect of taurine in DOCA-salt rats.
Fujita T; Sato Y
J Hypertens Suppl; 1984 Dec; 2(3):S563-5. PubMed ID: 6152784
[TBL] [Abstract][Full Text] [Related]
10. Dietary chloride and bicarbonate as determinants of desoxycorticosterone hypertension.
Kurtz TW; Morris RC
J Hypertens Suppl; 1984 Dec; 2(3):S371-3. PubMed ID: 6100744
[TBL] [Abstract][Full Text] [Related]
11. Hypertension in Brattleboro rats and the injurious influence of salt in youth.
Dlouhá H; Krecek J; Zicha J
Physiol Bohemoslov; 1981; 30(6):531-8. PubMed ID: 6459595
[TBL] [Abstract][Full Text] [Related]
12. Effect of endothelin-3 on blood pressure in conscious spontaneously hypertensive [SHR] and DOCA-salt hypertensive rats.
Januszewicz A; Loń S; Lapiński M; Styś A
J Physiol Pharmacol; 1994 Mar; 45(1):105-19. PubMed ID: 8043901
[TBL] [Abstract][Full Text] [Related]
13. Dietary chloride does not correlate with urinary thromboxane in deoxycorticosterone acetate-treated rats.
Theriot JA; Passmore JC; Jimenez AE; Fleming JT
J Lab Clin Med; 2000 Jun; 135(6):493-7. PubMed ID: 10850649
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
Kawanishi H; Hasegawa Y; Nakano D; Ohkita M; Takaoka M; Ohno Y; Matsumura Y
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138
[TBL] [Abstract][Full Text] [Related]
15. Induction of hypertension and cardiac hypertrophy in guinea pig by DOCA salt.
Tiritilli A; Ruff F
Methods Find Exp Clin Pharmacol; 1994; 16(6):391-6. PubMed ID: 7837830
[TBL] [Abstract][Full Text] [Related]
16. Involvement of endothelin-1 in deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy.
Matsumura Y; Fujita K; Miyazaki Y; Takaoka M; Morimoto S
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S456-8. PubMed ID: 8587444
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats.
Wang DS; Xie HH; Shen FM; Cai GJ; Su DF
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):545-52. PubMed ID: 16026514
[TBL] [Abstract][Full Text] [Related]
18. The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension.
Ni W; Fink GD; Watts SW
J Pharmacol Exp Ther; 2007 May; 321(2):485-91. PubMed ID: 17289838
[TBL] [Abstract][Full Text] [Related]
19. The effect of hypertension on serum nitric oxide and vascular endothelial growth factor concentrations. A study in DOCA-Salt hypertensive ovariectomized rats.
Khazaei M; Nematbakhsh M
Regul Pept; 2006 Jul; 135(1-2):91-4. PubMed ID: 16712976
[TBL] [Abstract][Full Text] [Related]
20. Contribution of central nitric oxide to the regulation of blood pressure and sodium balance in DOCA-salt hypertension.
Seto S; Nagao S; Ozeki S; Tetsuo H; Akahoshi M; Yano K
J Cardiovasc Pharmacol; 2006 May; 47(5):680-5. PubMed ID: 16775508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
